{"schema_version":"secwatch.filing_event.v1","accession":"0001006837-24-000154","form_type":"8-K","ticker":"VATE","cik":"0001006837","company_name":"INNOVATE Corp.","filed_at":"2024-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.337407+00:00","generated_at":"2026-05-30T04:14:45.447393+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"INNOVATE Q3 revenue $242.2M (-35.5% YoY); net loss $15.3M vs $7.3M loss YoY","bullets":["DBM Global revenue $232.8M (-37% YoY); gross margins expanded 360 bps to 18.8%","R2 record worldwide system unit sales growth of 416% YoY; $3.0M Life Sciences revenue","Spectrum revenue $6.4M (+$1M YoY); Adjusted EBITDA turned positive to $1.7M","Consolidated Adjusted EBITDA $16.8M (-24% YoY); cash $51.0M vs $80.8M Dec 2023","Reverse stock split 1-for-10 effected Aug 8, 2024; EPS retroactively adjusted"],"urls":{"canonical":"https://secwatch.observer/filing/0001006837-24-000154","json":"https://secwatch.observer/filing/0001006837-24-000154.json","markdown":"https://secwatch.observer/filing/0001006837-24-000154.md","text":"https://secwatch.observer/filing/0001006837-24-000154.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1006837/000100683724000154/0001006837-24-000154-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1006837/000100683724000154/hchc-20241106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T04:14:45.447393+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}